ZHOU Ting, CAI Jian, DUAN Jingjing, LIU Fenlian, HU Fangbao, LU Saihua. Liver damage caused by sodium valproate medication error: a case report[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 466-469. doi: 10.3969/j.issn.1006-0111.2019.05.016
Citation:
|
ZHOU Ting, CAI Jian, DUAN Jingjing, LIU Fenlian, HU Fangbao, LU Saihua. Liver damage caused by sodium valproate medication error: a case report[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 466-469. doi: 10.3969/j.issn.1006-0111.2019.05.016
|
Liver damage caused by sodium valproate medication error: a case report
- 1.
Department of Pharmacy, Central Hospital of Fengxian District, Shanghai 201499, China
- 2.
Department of Medical Affair, Mental Health Center of Fengxian District, Shanghai 201499, China
- 3.
ICU, Central Hospital of Fengxian District, Shanghai 201499, China
- Received Date: 2019-02-21
- Rev Recd Date:
2019-05-22
-
Abstract
Objective To analyze the participation effect of clinical pharmacist during the treatment process of sodium valproate in a patient with secondary epilepsy after stroke. Methods The correct dose and usage of sodium valproate under TDM,the most common ADR and the potential DI were introduced by clinical pharmacists who participated in the whole course treatment of sodium valproate. Results The convulsion was controlled and the liver damage caused by sodium valproate was recovered. Conclusion Clinical pharmacist should not only pay attention to ADRs under normal usage and dosage,but also pay special attention to the ability to deal with drug errors,so as to promote rational and individualized drug use.
-
References
[1]
|
黄希顺,廖卫平,李世绰,等.丙戊酸镁缓释片治疗癫痫临床应用专家共识[J], 癫痫与神经电生理杂志,2013,22(1):1-12. |
[2]
|
GLAUSER T,SHINNAR S,GLOSS D,et al.Evidence-based guideline:treatment of convulsive status epilepticus in children and adults:report of the Guideline Committee of the American Epilepsy Society[J].Epilepsy Curr,2016,16(1):48-61. |
[3]
|
KAYIHAN N,NENNESMO I,ERICZON BG,et al.Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage[J].Pediatr Transplant,2000,4(3):211-214. |
[4]
|
ANTONIUK SA,BRUCK I,HÖNNICKE LR,et al.Acute hepatic failure associated with valproic acid in children.Report of 3 cases[J]Arq Neuropsiquiatr,1996,54(4):,652-654. |
[5]
|
DICKINSON RG, BASSETT ML, SEARLE J,et al.Valproate hepatotoxicity:a review and report of two instances in adults[J].Clin Exp Neurol,1985,21,79-91. |
[6]
|
SHAABAN AA,EL-AGAMY DS.Cytoprotective effects of diallyl trisulfide against valproate-induced hepatotoxicity:new anticonvulsant strategy[J].Naunyn Schmiedebergs Arch Pharmacol,2017,390(9):919-928. |
[7]
|
AHMED N,ALJUHANI N,AL-HUJAILI HS,et al.Agmatine protects against sodium valproate-induced hepatic injury in mice via modulation of nuclear factor-KB/inducible nitric oxide synthetase pathway[J].J Biochem Mol Toxicol,2018,32(12):e22227. |
[8]
|
魏树礼.生物药剂学与药物动力学[M].北京:北京医科大学·中国协和医科大学联合出版社,1997:114. |
-
-
Proportional views
-